Cite
Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis.
MLA
Spampinato, Sofia, et al. “Risk Factors and Dose-Effects for Bladder Fistula, Bleeding and Cystitis after Radiotherapy with Imaged-Guided Adaptive Brachytherapy for Cervical Cancer: An EMBRACE Analysis.” Radiotherapy & Oncology, vol. 158, May 2021, pp. 312–20. EBSCOhost, https://doi.org/10.1016/j.radonc.2021.01.019.
APA
Spampinato, S., Fokdal, L. U., Pötter, R., Haie-Meder, C., Lindegaard, J. C., Schmid, M. P., Sturdza, A., Jürgenliemk-Schulz, I. M., Mahantshetty, U., Segedin, B., Bruheim, K., Hoskin, P., Rai, B., Huang, F., Cooper, R., van der Steen-Banasik, E., Van Limbergen, E., Sundset, M., Westerveld, H., & Nout, R. A. (2021). Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: An EMBRACE analysis. Radiotherapy & Oncology, 158, 312–320. https://doi.org/10.1016/j.radonc.2021.01.019
Chicago
Spampinato, Sofia, Lars U. Fokdal, Richard Pötter, Christine Haie-Meder, Jacob C. Lindegaard, Maximilian P. Schmid, Alina Sturdza, et al. 2021. “Risk Factors and Dose-Effects for Bladder Fistula, Bleeding and Cystitis after Radiotherapy with Imaged-Guided Adaptive Brachytherapy for Cervical Cancer: An EMBRACE Analysis.” Radiotherapy & Oncology 158 (May): 312–20. doi:10.1016/j.radonc.2021.01.019.